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Abstract 
The genetic diagnosis of rare monogenic diseases using exome/genome sequencing requires 
the true causal variant(s) to be identified from tens of thousands of observed variants. 
Typically a virtual gene panel approach is taken whereby only variants in genes known to 
cause phenotypes resembling the patient under investigation are considered. With the number 
of known monogenic gene-disease pairs exceeding 5000, manual curation of personalised 
virtual panels using exhaustive knowledge of the genetic basis of the human monogenic 
phenotypic spectrum is challenging.  
We present improved probabilistic methods for estimating phenotypic similarity based on 
Human Phenotype Ontology annotation. A limitation of existing methods for evaluating a 
disease’s similarity to a reference set is that reference diseases are typically represented as a 
series of binary (present/absent) observations of phenotypic terms. We evaluate a quantified 
disease reference set, using term frequency in phenotypic text descriptions to approximate 
term relevance.  
We demonstrate an improved ability to identify related diseases through the use of a 
quantified reference set, and that vector space similarity measures perform better than 
established information content-based measures. These improvements enable the generation 
of bespoke virtual gene panels, facilitating more accurate and efficient interpretation of 
genomic variant profiles from individuals with rare Mendelian disorders. These methods are 
available online at https://atlas.genetics.kcl.ac.uk/~jake/cgi-bin/patient_sim.py  
Keywords: Phenotype similarity, HPO, Genetic diagnosis, Monogenic, Rare disease, 
Mendelian, Variant prioritisation, whole exome sequencing, whole genome sequencing  
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Introduction 
The use of phenotype ontologies to capture patient phenotypes in a consistent and 
comparable manner is becoming standard practice to assist diagnostics and novel gene 
discovery in rare disease (Beaulieu et al., 2014; The Deciphering Developmental Disorders 
Study, 2014; Thompson et al., 2014). The phenotypic components of an individual’s disease 
are commonly collected using Human Phenotype Ontology (HPO) terms. The HPO (P. N. 
Robinson & Mundlos, 2010) is a specialised ontology designed to encompass phenotypic 
abnormalities that appear in human disease. Software has been developed to facilitate HPO 
term collection and storage (Girdea et al., 2013) and semantic similarity algorithms have been 
developed that calculate phenotypic similarity between patients to aid new gene discovery 
(Akawi et al., 2015; Westbury et al., 2015) or similarity between a patient’s phenotype(s) and 
a reference set of diseases to aid clinical and molecular diagnosis (Amberger, Bocchini, 
Schiettecatte, Scott, & Hamosh, 2014; Köhler et al., 2009). 
The increasing use of whole genome and whole exome sequencing necessitates the 
identification of a single disease-causing variant (or pair of variants for compound 
heterozygous disorders) from ~25,000 identified exonic sequence variants per individual 
(Hoischen et al., 2010; Musunuru et al., 2010; Ng et al., 2009). Often, standard variant 
filtering approaches are combined with virtual gene panels: prespecified lists of known 
causative genes that are prepared for specific phenotypic areas; only variants in the panel are 
considered as potentially causal. Virtual panels can be large – the DDG2P list (Wright et al., 
2015) encompasses over 1000 genes – and such gene lists don’t fully capitalise on the 
phenotypic similarity between the patient and known diseases, assuming a uniform 
distribution of probabilities across the panel that each gene could be causal. Selective 
augmentation of gene panels to create a more bespoke interpretation is often carried out, but 
with the number of known monogenic gene-disease pairs now exceeding 5,000 (Amberger et 
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al., 2014) it is becoming less feasible to manually curate personalised virtual panels for all 
phenotypes. 
Systematically collected patient phenotype data provides an opportunity to implement 
automated methodology that can utilise exhaustive knowledge of the human phenotypic 
spectrum in order to identify candidate genes. Methods that generate candidate gene lists 
tailored to the patient offer improvements over standard virtual gene panel approaches. 
Firstly, automated searching across the entire human phenotypic spectrum mitigates the 
aforementioned issue of the growing number of known monogenic gene-disease pairs. 
Secondly, within a virtual panel all genes are considered equally likely to cause the disease, 
whereas searching across the entire human phenotypic spectrum confers the ability to score 
each gene based on its relevance to the patient’s disease, enabling the construction of more 
concise and relevant gene panels. 
Approaches have been developed that query patient phenotype terms against a reference set 
to assist clinical and molecular diagnosis (Köhler et al., 2009; Peter N. Robinson et al., 2014; 
Singleton et al., 2014). These methods incorporate ontology-based similarity measures and 
the reference set consists of curated phenotype annotations to known Mendelian disorders. 
Whilst these methods have been shown to be effective in a handful of cases or simulated 
patients/exomes, the underpinning phenotype similarity metrics have limitations. Clinical 
features are annotated to phenotypes as binary present/absent observations which are unable 
to describe the relevance of each phenotypic feature to the overall disease. For example, 
primary microcephaly-1 (MIM #251200) is characterised by 16 ‘Phenotypic abnormality’ 
terms in the curated HPO annotation set, including the core feature ‘Microcephaly’ (HP: 
0000252) as well as other features of lower penetrance (such as ‘Renal hypoplasia/aplasia’ – 
HP: 0008678). Binary annotation is unable to reflect the relative importance of terms in 
similarity calculations, in this case weighting the cardinal ‘Microcephaly’ feature equally to 
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non-obligate features such as ‘Renal hypoplasia’ and ‘Hyperreflexia’. Although penetrance 
data is recorded for a proportion of HPO phenotype annotations, termwise similarity 
measures such as the Resnik algorithm (Resnik, 1999) do not utilise this information, 
although BOQA (Bauer, Köhler, Schulz, & Robinson, 2012) is a Bayesian query tool that has 
been built to utilise the limited existing penetrance information.  
In light of these limitations, we first investigated the use of a quantitatively annotated 
reference disease set, where HPO terms were weighted by relevance to their diseases. We 
used simple text mining of free-text disease descriptions to generate phenotype annotations, 
and used term frequency to approximate relevance. The utility of text-mined reference 
annotations was established by comparison to the curated annotation set of the same diseases 
employed by the Phenomizer, a differential diagnostic tool for human Mendelian disorders 
(Köhler et al., 2009). We also compared the quantified text-mined phenotype annotations 
against an unquantified version of the same annotation set. Secondly, we used a vector space 
model (VSM) to evaluate similarity between HPO-annotated diseases, comparing this to the 
Resnik similarity algorithm implemented in the Phenomizer (Resnik, 1999), as well as the 
BOQA algorithm (Bauer et al., 2012). Quantification of phenotype terms and the use of 
vector space similarity has been used outside of a clinical context in human phenome analysis 
(Lage et al., 2007; van Driel, Bruggeman, Vriend, Brunner, & Leunissen, 2006) and we 
hypothesised that the use of term quantification to represent relevance, combined with a 
suitable similarity measure would enhance our ability to identify similar diseases. 
To test this hypothesis we developed evaluation metrics using OMIM Phenotypic Series (PS) 
(Amberger et al., 2014) as a set of known similar diseases. We evaluated methods based on 
their ability to group these diseases close to each other. Finally, we benchmarked different 
disease reference annotations and similarity metrics using an external diagnosed patient 
dataset (The Deciphering Developmental Disorders Study, 2014) in which patient HPO terms 
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were recorded prior to their genetic diagnosis (Wright et al., 2015). We evaluated the 
different reference sets (and query methods) based on their ability to return the correct gene 
for each patient after querying their HPO terms. 
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Materials and methods 
Phenotype annotation 
Manually curated OMIM phenotype annotations are made publically available for download 
by the HPO group (build #1233, Jan 13 2016, downloaded 09/02/16). Only ‘phenotypic 
abnormality’ annotations were used to ensure equivalence with annotations used by 
Phenomizer. 
In order to text-mine phenotype annotations, the descriptive text was first extracted from 
OMIM (date: 05/02/16). The text entries were then submitted to Annotator (Shah et al., 2009) 
(date: 08/02/16), a free-to-use resource made available by the National Centre of Biomedical 
Ontology (Musen et al., 2012) which infers ontology annotations from text. Annotator utilises 
‘an exact string comparison (a “direct” match) between the text and ontology term names, 
synonyms, and IDs’ (Shah et al., 2009), making it a reasonably simple text-mining tool. HPO 
terms were filtered to include only ‘Phenotypic abnormality’ terms (HP: 0000118). Text-
mined phenotype annotation term counts were converted to penetrance statistics (to enable 
compatibility with BOQA) by dividing the count of each annotated HPO term by the highest 
HPO count within the phenotype. 
Phenotype similarity 
Once annotated, similarity between phenotypes was calculated. The performance of the 
Resnik algorithm implemented in the Phenomizer (Köhler et al., 2009; Resnik, 1999) and 
BOQA (Bauer et al., 2012) were compared to vector space, which is used in various 
information retrieval methods. Diseases are represented as vectors, with each dimension 
indicating the presence (or absence) of a particular HPO term. Similarity between two disease 
vectors is measured using the cosine of the angle between them (Equation 1). In this 
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application of cosine similarity, the score ranges from 1 (corresponding to an angle of 0⁰, 
indicating identical vectors) to 0 (corresponding to 90⁰, indicating orthogonality). 
Equation 1: Cosine similarity between feature vectors Q and D 
𝑠𝑖𝑚(𝑄, 𝐷) = cos 𝜃 =  
𝑄 ∙ 𝐷
‖𝑄‖ ∙ ‖𝐷‖
 
In its simplest form a vector space model requires vector components to be set to 1 
(indicating the HPO term is present) or 0 (indicating the HPO term is absent). It can be 
advanced from this simple binary setting using a variety of techniques (our implementation 
incorporates all of the following): 
Use of the semantic inheritance structure of terms; recalling that annotation of a particular 
ontology term implicitly annotates every ancestor of that term on the DAG, ancestral terms 
can also be included in the disease vectors. 
Using term frequency; pertinent when using text-mined annotations, the number of times a 
disease is annotated with a particular HPO term is used.  
Use of term weights; identical to the Resnik term-Information Content calculation, vector 
components can be modified by multiplying them by the inverse document frequency (IDF; 
Equation 2) of their terms. This up-weights vector features that correspond to specific terms.  
Equation 2: IDF adjustment for term t 
𝐼𝐷𝐹(𝑡) = log (
𝑡𝑜𝑡𝑎𝑙 𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒𝑠
𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒𝑠 𝑎𝑛𝑛𝑜𝑡𝑎𝑡𝑒𝑑 𝑤𝑖𝑡ℎ 𝑡
) 
Simulated queries (interpolated-precision recall) 
When benchmarking information retrieval (IR) methods, approaches generally involve 
defining a set of entities (diseases) within the corpus that are ‘known’ to be similar (by 
consulting literature/experts) and then observing how well a particular method performs in 
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classifying such entities as similar. The approach developed here made use of the OMIM 
phenotypic series (PS) as the set of known similar diseases. The OMIM phenotypic series are 
defined as a set of ‘phenotype entries [that] overlap significantly in their clinical 
manifestations’, and that they are classified according to clinical judgement, not computed 
similarity (Amberger et al., 2014). Phenotypic series have variable size, grouping from 2 to 
78 diseases (mean = 8.03). There are 353 phenotypic series, covering 2785 diseases in the 
OMIM catalogue (PS information downloaded: 15/02/16).  
For each disease in a phenotypic series, the disease was removed and its terms used as a 
query to the remaining OMIM reference set. The diseases in the remaining set were ranked 
by similarity to the query, evaluating based on the ranks of the diseases within the same 
phenotypic series. Methods were evaluated by conducting this test on all diseases in 
phenotypic series and aggregating the results. Only diseases that were annotated by all 
methods (Table 1) were included in the analysis and diseases in multiple phenotypic series 
were not used (n=47), leaving 2317 phenotype queries (319 PS).  
Precision-recall was used to evaluate the OMIM phenotypic series queries because these 
metrics are more applicable than ROC metrics when there is a highly skewed class 
distribution (a maximum of 2% of the query results are classed “positive”; the rest will be 
classed “negative”). Starting from rank 1 and iterating through further ranks, the precision 
and recall were calculated (defined in Equation 3 and Equation 4) for each query. 
Equation 3: Precision (P) for a query at rank r 
𝑃𝑟 =  
𝑠𝑖𝑚𝑖𝑙𝑎𝑟 𝑑𝑖𝑠𝑒𝑎𝑠𝑒𝑠 𝑤𝑖𝑡ℎ𝑖𝑛 𝑟𝑎𝑛𝑘 𝑟
𝑟
 
Equation 4: Recall (R) for a query at rank r 
𝑅𝑟  =  
𝑠𝑖𝑚𝑖𝑙𝑎𝑟 𝑑𝑖𝑠𝑒𝑎𝑠𝑒𝑠 𝑤𝑖𝑡ℎ𝑖𝑛 𝑟𝑎𝑛𝑘 𝑟
𝑡𝑜𝑡𝑎𝑙 𝑠𝑖𝑚𝑖𝑙𝑎𝑟 𝑑𝑖𝑠𝑒𝑎𝑠𝑒𝑠
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To overcome difficulties in averaging performance over queries with variable numbers of 
positive results (due to the variable size of phenotypic series), an interpolation step was 
included. This involved defining 11 standard recall points (0 … 0.1 … 0.2 … … 1) and using 
the maximum precision found above each point as the 11-point interpolated precision recall 
(Equation 5).  
Equation 5: Interpolated precision (I) for a query at standard recall level R 
𝐼𝑅 =  max
𝑅′≥ 𝑅
𝑃(𝑅′) 
To evaluate a method where n queries were tested, the n interpolated precision points at each 
standard recall point were averaged, showing the decline of precision as recall increases. To 
facilitate statistical comparison between methods, the mean average precision (MAP) was 
also calculated across the queries (Equation 6). MAP is highly correlated with the area under 
a precision-recall curve and the single value metrics (rather than a curve) enable simple 
hypothesis testing using a Student’s paired t test (Smucker, Allan, & Carterette, 2007). 
Equation 6: Average precision (AP) for a query where N is the total number of results, d is the number of 
relevant results, P(k) is the precision at k results and ∆r(k) is the change in recall from cut-off k-1 and k (thus 
only permits precision at ‘relevant’ ranks to be averaged). 
𝐴𝑃 =
1
𝑑
∑ 𝑃(𝑘)∆𝑟(𝑘)
𝑁
𝑘=1
 
DDD patient queries 
To observe method performance in real cases of rare disease, patient diagnoses and 
phenotype information from the DDD consortium (The Deciphering Developmental 
Disorders Study, 2014) were used for additional benchmarking. A cohort of 1,133 patients 
with undiagnosed developmental disorders underwent exome sequencing and aCGH to 
identify SNVs, indels and CNVs. Following an analysis pipeline of filtering and evaluating 
variants that appear in the curated DDG2P developmental gene list (Wright et al., 2015) 351 
11 
 
patients were returned a (probable) diagnosis and their causative variants were released along 
with HPO terms describing their disease. Of these 351 diagnoses, 283 were due to pathogenic 
variants in a single gene (rather than digenic diagnoses, CNVs, UPDs or mosaicisms). 258 of 
these monogenic diagnoses were in a gene that mapped to an OMIM phenotype in all 3 
reference sets (Table 1). The HPO terms for each patient were queried to the different disease 
reference sets with the different similarity methods. Only diseases in all reference sets were 
queried (n=6518). The 6518 phenotypic similarity scores for each query were converted to 
1268 developmental gene scores by taking the top disease score for each OMIM-mapped 
gene in the DDG2P list (downloaded: 05/01/16) (Firth et al., 2009). Methods were evaluated 
based on their ability to prioritise the causative gene of each patient using only the 
phenotypic information provided. Analysis was initially conducted based on the ranks that 
each method assigned the correct causative gene in each patient. 
Score-probability normalisation 
The methods were tested further by undertaking analysis that quantified method performance 
ahead of choosing a developmental gene at random. Phenotypic similarity scores were 
converted to probabilities, which were then converted to normalised gene probabilities which 
could be plot against a baseline of the probability of selecting a random gene from the 
DDG2P list (n=1268). Rather than assuming a linear relationship between the phenotypic 
similarity score and the probability of similarity, we used similarity scores between diseases 
in OMIM phenotypic series to characterise this relationship. For each annotation/similarity 
method combination the following was done – for each disease X in a phenotypic series, we 
queried the HPO terms of X to the remaining annotation set. Similarity scores between X and 
diseases in the same series were recorded as examples of scores between truly similar 
diseases, while scores between X and all other phenotypes were recorded as examples of 
scores between non-similar diseases. The spectrum of recorded similarity scores was split 
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into bins at regular (100) intervals and the proportion of similarity scores representing true 
similarity T could be calculated for each bin (Figure 1, Equation 7). A generalised logistic 
function (Equation 8) was chosen to fit the data. 
Equation 7: Calculation of T for each bin – TP is the number of scores between “true matches” within the bin; 
ALL is the total number of scores within the bin. 
𝑇𝑏𝑖𝑛 =
𝑇𝑃𝑏𝑖𝑛
𝐴𝐿𝐿𝑏𝑖𝑛
 
Equation 8: Generalised logistic function fit to the T data using midpoint x of each bin. Data was fit to using 
non-linear least squares, optimising variables K, Q, B, M and v. 
𝑇 =
𝐾
(1 + 𝑄𝑒−𝐵(𝑥−𝑀))1/𝑣
 
The generalised logistic function (with appropriate calculated variables delineated in (Table 
2)) was used to rescale the phenotypic similarity scores. The rescaled phenotypic similarity 
scores were then converted to gene scores using the highest disease score that mapped to each 
gene, and normalised so all gene scores summed to one.  
  
13 
 
Results 
Phenotype annotation 
We initially extracted HPO terms (and their frequencies) from OMIM disease descriptions 
using simple text mining (Materials and Methods). We compared the numbers of diseases 
that could be annotated and HPO terms extracted by text mining to the annotations curated by 
the HPO team (Köhler et al., 2014) (Table 1). Compared to the curated annotations, 
unquantified text mining assigned more phenotype terms to each disease on average, but 
detected a far narrower range of different terms overall. Text mining detected a lower 
proportion of the full range of HPO terms due to only using the OMIM text description as an 
input, whereas the curated annotations utilise additional data sources, such as published 
clinical studies and individual clinical experience. However, text mining resulted in an 
increased number of annotations because terms were encountered in a greater number of 
different disease descriptions on average. These terms were more general, hence having a 
lower average distance to the root HPO term (HP:0000001 – ‘All’). When the text-mined 
terms were quantified, it resulted in over double the total annotation count. 
Simulated queries 
We developed a series of evaluation metrics to benchmark the performance of different 
combinations of phenotype annotation and similarity methods. We used the OMIM 
phenotypic series (PS), which comprise groups of clinically linked diseases, as a set of known 
similar diseases to generate queries. Only diseases that were annotated by all methods (Table 
1) were included in the analysis and diseases in multiple phenotypic series were not queried 
(n=47), leaving 2317 disease queries (from 319 PS). We used precision-recall, a measure 
commonly utilised when evaluating information retrieval (IR) systems, to evaluate method 
performance on the phenotypic series queries (Equation 3, Equation 4). To overcome issues 
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of averaging over queries where the phenotypic series size was variable, precision-recall was 
converted to 11-point interpolated precision-recall (Equation 5). For each method 2317 
queries were tested, so at each standard recall point the 2317 interpolated precision points 
were averaged to show the decline of precision as recall increases. Mean average precision 
(Equation 6) was also calculated to facilitate statistical comparison between methods using a 
paired Student’s t test. P-values have been corrected for multiple testing under dependency 
(Benjamini & Yekutieli, 2001) unless stated otherwise.  
Here we evaluated two different similarity measures (Vector space and Resnik). When HPO 
annotations were not quantified (curated (c) and unquantified text mining (u)) the 
performance of vector space similarity had a modest but significant advantage over Resnik 
(Pc = 4.62 × 10
-13, Pu = 4.47 × 10
-14), but vector space was far superior when the HPO terms 
were quantified (Pq = 2.83 × 10
-95) (Figure 2A). When annotations were not quantified the 
similarity in performance between the two algorithms was expected due to their similar 
premise.  
When phenotype annotations are quantified, vector space similarity performs better due to its 
ability to down-weight the vector features of more general terms (as they will have a lower 
IDF/IC as defined in Equation 2 (Materials and Methods)) and noise terms (which are likely 
to be found at a lower frequency to ‘genuine’ terms) that text mining is more prone to 
detecting. Using vector space similarity, we assessed the performance of each annotation 
method. We found that quantified text mining is superior to curated annotation (P = 9.02 × 
10-58), although unquantified text mining is inferior to curated and quantified methods (P = 
2.38 × 10-10 and P = 1.02 × 10-151, respectively). Having observed that querying a disease 
consisting of quantified phenotype terms against a quantified reference set was the optimal 
setting, we tested whether a quantified reference set was superior to the others even when the 
query was not quantified. 
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The quantified reference disease set compares favourably to both the curated and 
unquantified text-mined reference sets when using unquantified text-mined queries (P = 2.55 
× 10-64 and P = 1.38 × 10-63, respectively) (Figure 2B). However, when querying with curated 
phenotype annotations, a quantified reference set provides no clear benefit in comparison to 
the curated annotation set (P = 0.658a, Figure 2C). Curated queries were more effective with 
the curated reference set while text-mined queries were more effective with the text-mined 
reference sets.  
DDD patient queries 
Rank-based analysis 
For further benchmarking we used an independent patient dataset released by the DDD 
consortium (The Deciphering Developmental Disorders Study, 2014) which contained the 
genetic diagnosis for 351 patients with developmental disorders as well as the HPO terms 
used to describe their disease prior to diagnosis. We used different combinations of reference 
disease sets and phenotype similarity calculation methods to rank genes in the DDG2P list 
(used as a virtual panel in the original study (Wright et al., 2015)) to determine which 
methods were most effective in prioritising genes within this large list. We ranked genes by 
querying the HPO terms for each of the 258 patients with monogenic disease diagnoses to the 
different OMIM disease reference sets. These disease similarity scores were converted to 
gene scores using the OMIM gene-disease mappings (taking the top disease score for genes 
that cause multiple OMIM diseases). The ranks of the correct gene for each of the 258 
patients were compared across methods using the Wilcoxon test followed by adjustment for 
multiple testing under dependence. 
                                                          
a Without multiple testing correction 
16 
 
Contrary to our findings based on OMIM PS, we found that queries made using vector space 
similarity showed no significant improvement over Resnik with the unquantified text-mined 
reference set (P = 0.481a), but the use of vector space resulted in an improvement for the 
curated (P = 0.0210) and quantified text-mined (P = 1.57 × 10-4) reference sets (Figure 3). 
Comparing reference sets under vector space similarity, we found that the unquantified text-
mined annotation set showed no significant improvement over curated annotations (P = 
0.36a), but the quantified set showed a significant improvement in correct phenotype ranks (P 
= 1.39 × 10-4). The quantified text-mined reference set also showed a significant 
improvement in comparison to its unquantified counterpart (P = 1.03 × 10-7), supporting our 
previous observations in the OMIM PS benchmark dataset. Using quantified text mining in 
combination with vector space showed dramatic improvements over using BOQA with both 
the same quantified text-mined reference set, as well as the curated set for which BOQA 
could utilise penetrance statistics (P = 1.85 × 10-6 and P = 8.62 × 10-6 respectively). 
Interestingly, for each reference set, using both BOQA and Resnik similarity methods 
predicted more correct genes at rank 1 than using vector space, although this trend is reversed 
at rank 10, where vector space becomes more sensitive than other similarity methods.   
Score-based analysis 
In further analysis we attempted to re-scale the similarity scores to reflect the probability of 
causality for each of the genes in the DDG2P list based on the phenotypic similarity score 
between each DDD patient and the reference diseases. After querying the patient HPO terms 
using the different methods, the generalised logistic function (Equation 8, with appropriate 
variables delineated in Table 2) was used to rescale the phenotypic similarity scores. BOQA 
outputs a probability for each disease and therefore rescaling isn’t required. The rescaled 
similarity scores were then converted to DDG2P gene scores using the OMIM gene-disease 
mappings (taking the top phenotype score for genes that cause multiple OMIM diseases) and 
17 
 
normalised to sum to one to give an estimate of the probability for each gene. These gene 
scores were plotted against a baseline of the probability of selecting a random gene from the 
DDG2P list (Figure 4). 
For each reference set, vector space similarity outperformed Resnik similarity in assigning a 
higher average probability to the disease-causing gene (Table 3), although this advantage is 
significant only for the curated (P = 2.03 × 10-3) and the quantified text-mined reference sets 
(P = 1.91 × 10-3).  Compared to vector space and Resnik, using BOQA to measure patient 
similarity to the respective reference sets resulted in a much higher mean probability assigned 
to the correct gene, although this was due to a handful of outlying patients having a very high 
probability assigned to the causative gene (Each BOQA method had 15-25 patients with 
Δ>0.2 for the correct gene). However, both BOQA and Resnik approaches resulted in a low 
median Δ and performed poorly for the majority of patients (in the best case, 61 of 258 
patients had a positive Δ). This was also the case when querying the curated reference set 
using vector space, which achieved a high average probability but was also offset by poor 
median performance, with over half of the correct genes having a lower probability than 
selecting the gene at random from the DDG2P list. The quantified reference set combined 
with vector space achieved the highest median probability for the correct genes. The 
quantified reference sets also achieved the highest number of patients with a positive Δ 
(probability subtracted by prior) for the correct gene. Additionally, the Resnik similarity 
measure has a slight advantage over vector space in this respect.  
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Discussion 
Here we present a method for the identification of similar diseases through annotation with 
basic text mining, including term quantification to make optimal use of the most relevant 
phenotypic features. We have shown that this approach offers a clear advantage over current 
tools that use binary annotation settings to indicate only the presence or absence of clinical 
terms. Ideally, clinical terms could be quantified in the representation of a genetic disease by 
using data on their prevalence among individuals having that disease. However, such a 
comprehensive dataset does not yet exist (41% of current HPO curated annotations have 
quantification information with 48% of diseases containing at least one quantified phenotype 
term) and it is unclear how some currently employed similarity methods can integrate 
knowledge of feature prevalence. Whilst frequency extracted from text mining phenotypic 
descriptions is not expected to fully capture the penetrance of terms across affected cases, we 
find a weak positive correlation where term penetrance data is available (Supp. Figure S1) 
and it serves as an effective weighting scheme that encompasses all phenotypes. It seems 
likely that the performance of this text-mining approach could further improve through the 
use of additional relevant input phenotype descriptions. For example, text input from OMIM 
literature references and further literature on MEDLINE could be suitable. Despite limitations 
of this method of annotation, we find that this relatively simple method of term quantification 
aids the retrieval of similar diseases as well as the downstream identification of genes. 
Additionally, we investigated a vector space similarity measure as an alternative to currently 
used phenotype similarity measures, as its construction is less sensitive to noise associated 
with quantitative annotation. 
In our initial validation stage we tested the ability of different combinations of annotation and 
similarity methods to group known similar OMIM diseases closely to each other. We found 
that quantification of phenotypic information enhanced our ability to identify similar 
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diseases, compared to both the curated annotation set and an unquantified version of the same 
reference set. Vector space similarity performed roughly as well as the Resnik measure of 
similarity when unquantified reference sets were used, but greatly outperformed it when 
quantifying reference phenotype terms. The use of OMIM phenotypic series as the known 
similar diseases enabled the methods to be tested across a great number of phenotypes (~35% 
of annotated OMIM records), representing a very diverse range of diseases. Although these 
groupings are curated based on clinical judgment rather than computed similarity (and thus 
not biased by annotations) the phenotypic series information may have biased the various 
annotation sets through the recycling of descriptive text.  However, we did observe 
concordance between the DDD patient benchmarking and these OMIM PS tests. 
The DDD patient diagnosis dataset used in subsequent testing should contain no such bias 
because each patient’s HPO terms were recorded by their UK NHS or Irish Regional 
Genetics Service prior to diagnosis (Wright et al., 2015). When patient HPO terms were 
queried to the different disease reference sets, the quantified text-mined annotation set 
provided a significant benefit ahead of both unquantified reference sets in identifying relevant 
diseases for each patient and therefore ranking the true causative genes highly. Interestingly, 
the use of BOQA resulted in the identification of the diagnostic gene with very high 
confidence in a small number of patients (<10%) and predicted more causal genes at rank 1, 
although our methods were generally able to assign a higher rank and more probability to the 
causal gene in the majority of patient population. Despite the advances shown by our method, 
sensitivity remains relatively low for the challenging task of identifying disease-causing gene. 
Each combination of methods tested herein failed to assign a high rank to the causative 
developmental gene for a large subset of DDD patients. The top-performing method only 
found the causative gene within rank 10 in 23% of cases and rank 100 in 56% of cases 
(Figure 3). However, this is likely to reflect the dataset being enriched for patients that had a 
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developmental disorder that was initially difficult to diagnose. More straightforward cases 
would therefore be depleted in this dataset (The Deciphering Developmental Disorders Study, 
2014), and we would expect this methodology to perform better at solving such cases - a 
valid alternative application. In addition, the DDD study also identified novel gene-
phenotype links, such as that of the MED13L gene. MED13L variants have previously been 
described in patients with congenital heart defects such as dextro-looped transposition of the 
great arteries (d-TGA; MIM #608808) (Muncke et al., 2003), but this study identified 8 
patients with variants in MED13L gene that had intellectual disability but lacked congenital 
heart malformations (Adegbola et al., 2015). 
Text mining for phenotype annotations can also have utility in a clinical context; its quick 
and systematic nature could make it highly valuable in large clinical genetics services. 
Manual assignment of clinical ontology terms has only recently become widely undertaken 
and is performed with variable degrees of diligence. We propose that as an alternative, text 
mining of patient clinic letters for phenotypic terms would enable rapid and systematic 
definition of patient phenotypes. Term quantification would enable scoring of terms based on 
the belief that they are truly descriptive of the patient, although future work could incorporate 
more sophisticated text mining features such as detection of term negation and modifiers for 
severity. Text mining patient records over a long period would also enable longitudinal 
phenotype data to be collected. This is particularly pertinent in the context of syndromes 
where different clinical features appear at different ages. Patients could then be compared 
based on their clinical presentation at defined timepoints. 
To summarise, we have shown that quantifying clinical terms can be an effective method of 
refining phenotype descriptions, beyond a simple representation as binary observations. 
When calculating similarity, term frequency becomes an additional feature by which terms 
can be weighted rather than only their IC/IDF. We have also utilised a suitable method for 
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calculating similarity between quantified phenotypic definitions, vector space models, which 
is able to take into account term frequency and specificity. Our methods show improvement 
compared to currently employed methods in classifying related OMIM diseases as similar. 
Querying patient phenotypes from a genuine developmental disorder study to a quantified 
disease reference set displayed a significant improvement in aiding the identification of the 
correct gene. These methods are available for use online at: 
https://atlas.genetics.kcl.ac.uk/~jake/cgi-bin/patient_sim.py  
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Figure Legends 
Figure 1: T, the fraction of true positive scores within each bin when OMIM PS phenotypes 
were queried using different annotation and similarity methods. Additionally the sigmoid 
curve fit is displayed for each setting with the solid lines. 
Figure 2: Average 11-point interpolated precision-recall for 2317 queries using different 
combinations of phenotype annotation and similarity methods. Similarity measure is denoted 
by linestyle (solid = vector space; dashed = Resnik). Reference set annotation and query 
annotation is denoted by line and dot colour respectively (red = HPO curated annotation; 
green = unquantified text mining; blue = quantified text mining). Area under the precision-
recall curve and mean average precision (MAP) are indicated in the legend. A: all 
combinations of annotation and similarity measure were tested, keeping the annotation setting 
of the query the same as the annotation of the reference set. B: queries were made using the 
unquantified text-mined set only. C: queries were made using the curated set only. B&C: only 
the vector space similarity measure was used as it was superior to Resnik in all cases. 
Figure 3: Ranks of the ‘correct’ gene for 258 queries from the diagnosed DDD patient 
dataset, for the different combinations of reference annotations and query methods. Only 
phenotypes in all reference sets were queried (n=6518) and phenotype ranks were converted 
to DDG2P gene ranks (n=1268). Boxplot limits represent the 5th and 95th percentiles; black 
diamond indicates the mean rank. 
Figure 4: Probability (after logistic function rescaling) assigned to the correct gene for 258 
DDD patient queries to different reference sets using different query methods. Probability 
was plot against a baseline of selecting a DDG2P gene at random (1/1268). Number of 
patients for which probability is higher than randomly selecting a DDG2P gene is indicated 
on the plot. 
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Tables 
Annotation method Phenotypes Total annotations Terms used Average 
phenotypes 
per term 
Average 
distance 
to root 
Curated 6902 90236 6825 13.2 6.50 
Text mining, unquantified 7600 105644 4719 22.4 6.43 
Text mining, quantified 7600 230274 4719 22.4 6.43 
      
Curated N 6518 88533 6765 13.1 6.50 
Text-mined, unquantified N 6518 99126 4679 21.2 6.43 
Text-mined, quantified N 6518 215895 4679 21.2 6.43 
      
Curated X 384 1703 918 1.86 6.11 
Text-mined, unquantified X 1082 6518 1598 4.08 6.19 
Text-mined, quantified X 1082 14379 1598 4.08 6.19 
Table 1: Metrics for different methods of annotating the OMIM phenotype catalogue with 
HPO terms. The subscript N denotes the group of phenotypes captured by all annotation 
methods. The subscript X denotes those phenotypes exclusively captured by each annotation 
method (curated vs. text-mined). 
 
Annotation method Similarity method K Q B M v 
Curated 
Resnik 
0.847 6.92 0.832 -0.626 0.21 
Text mining, unquantified 1 3.5 0.965 1.15 0.334 
Text mining, quantified 1 1.54 1.09 3.1 0.63 
Curated 
Vector space 
0.81 0.515 6.15 0.207 0.0569 
Text mining, unquantified 1 0.628 5.46 0.753 0.598 
Text mining, quantified 0.678 2.17 15.1 0.807 2.02 
Table 2: Optimised generalised logistic function variables from Equation 8 for each 
combination of annotation and similarity method. Functions are plot in Figure 1. 
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Annotation method Similarit
y method 
Average 
Δ 
Average 
fold 
change 
Median Δ Median 
fold 
change 
n(Δ > 0) 
Curated 
Resnik 
2.31E-03 2.927 9.26E-04 1.175 198 
Text mining, unquantified 2.69E-03 3.414 1.12E-03 1.422 204 
Text mining, quantified 1.88E-03 2.388 9.01E-04 1.143 220 
Curated 
Vector 
space 
2.27E-02 28.731 -5.86E-05 -0.074 128 
Text mining, unquantified 2.79E-03 3.532 1.05E-03 1.327 196 
Text mining, quantified 3.43E-03 4.345 1.17E-03 1.479 212 
Curated 
BOQA 
5.33E-02 67.529 -7.79E-04 -0.987 52 
Text mining, unquantified 8.31E-02 105.426 -7.69E-04 -0.975 59 
Text mining, quantified 7.65E-02 97.020 -7.54E-04 -0.956 61 
Curated, quantified 5.21E-02 66.053 -7.69E-04 -0.975 52 
Table 3: Metrics for score-based analysis (after logistic function rescaling) of different 
phenotype annotation and similarity methods used to identify the causative genes for 
diagnosed DDD patients (from Figure 4). Δ = probability – prior; Fold change = Δ/prior. 
 
